INMD
I got more pessimistic after listening to recent investor presentation, just felt the tone was they were trying to make it clear that q3 last year was abnormally strong, and the comp wasn't gonna be pretty, didn't expect it too be as bad as it was. But the presentation was later in the quarter, so for some reason got negative when I heard the investor presentation for some reason. Set off my investor Alarm bells, now I didn't Think it would sell off this bad, but the news was worse than I thought as well. Time will tell. But I think INMD is probably somewhat attractive at this level. But that can't be said about alot of stocks at this point. And the growth story is now a bit in question here, keep in mind although q4 is expected to bounce back if they hit revised guidance (Keep in mind that is like 2-9% rev growth so growth is definetly slowing, so it is not just seasonality here. We have the isreal thing, and we have to worry about higher tax rates at some point as well as ABH pointed out. Plus there medical services are more consumer discretionary that other healthcare services, which if you think the economy or consumer spending is gonna slow that is another headwind. Having said that the stock is still cheap and it has been destroyed as well. Hence somewhat attractive is what I call it. All is just my opinion, and I could always be wrong though.
News 
Market Data 
Discover 
AI
